Kalbe Farma Price To Earning vs. Price To Book

PTKFY Stock  USD 21.05  0.00  0.00%   
Based on the key profitability measurements obtained from Kalbe Farma's financial statements, Kalbe Farma Tbk may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in May. Profitability indicators assess Kalbe Farma's ability to earn profits and add value for shareholders.
For Kalbe Farma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Kalbe Farma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Kalbe Farma Tbk utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Kalbe Farma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Kalbe Farma Tbk over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Please note, there is a significant difference between Kalbe Farma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kalbe Farma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kalbe Farma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Kalbe Farma Tbk Price To Book vs. Price To Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Kalbe Farma's current stock value. Our valuation model uses many indicators to compare Kalbe Farma value to that of its competitors to determine the firm's financial worth.
Kalbe Farma Tbk is considered to be number one stock in price to earning category among related companies. It is considered to be number one stock in price to book category among related companies fabricating about  0.15  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Kalbe Farma Tbk is roughly  6.80 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kalbe Farma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kalbe Farma's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kalbe Farma's earnings, one of the primary drivers of an investment's value.

Kalbe Price To Book vs. Price To Earning

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Kalbe Farma

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
32.31 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Kalbe Farma

P/B

 = 

MV Per Share

BV Per Share

 = 
4.75 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Kalbe Price To Book Comparison

Kalbe Farma is currently under evaluation in price to book category among related companies.

Kalbe Farma Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Kalbe Farma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Kalbe Farma will eventually generate negative long term returns. The profitability progress is the general direction of Kalbe Farma's change in net profit over the period of time. It can combine multiple indicators of Kalbe Farma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia. Pt Kalbe operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 12501 people.

Kalbe Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Kalbe Farma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Kalbe Farma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Kalbe Farma's important profitability drivers and their relationship over time.

Use Kalbe Farma in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kalbe Farma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalbe Farma will appreciate offsetting losses from the drop in the long position's value.

Kalbe Farma Pair Trading

Kalbe Farma Tbk Pair Trading Analysis

The ability to find closely correlated positions to Kalbe Farma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kalbe Farma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kalbe Farma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kalbe Farma Tbk to buy it.
The correlation of Kalbe Farma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kalbe Farma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kalbe Farma Tbk moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kalbe Farma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Kalbe Farma position

In addition to having Kalbe Farma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run FinTech Thematic Idea Now

FinTech
FinTech Theme
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The FinTech theme has 81 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize FinTech Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Equity Center.
Note that the Kalbe Farma Tbk information on this page should be used as a complementary analysis to other Kalbe Farma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Kalbe Pink Sheet analysis

When running Kalbe Farma's price analysis, check to measure Kalbe Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalbe Farma is operating at the current time. Most of Kalbe Farma's value examination focuses on studying past and present price action to predict the probability of Kalbe Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalbe Farma's price. Additionally, you may evaluate how the addition of Kalbe Farma to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
To fully project Kalbe Farma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Kalbe Farma Tbk at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Kalbe Farma's income statement, its balance sheet, and the statement of cash flows.
Potential Kalbe Farma investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Kalbe Farma investors may work on each financial statement separately, they are all related. The changes in Kalbe Farma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Kalbe Farma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.